About this trial
Group (A): This group will receive fentanyl infusion at a dose of (0.5μg/kg/h) all through the whole operation plus ultrasound guided bilateral superficial parasternal intercostal Plane block which will be done by injecting 0.4ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) at each side3.
Group (B): This group will receive fentanyl infusion at a dose of (0.5μg/kg/h) all through the whole operation plus Ultrasound guided bilateral ESPB which will be done by injecting 0.4ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) at each side .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
RACHS-1: Categories 1, 2 and 3
Patients undergoing corrective cardiac surgeries with midline sternotomy incision.
Redo surgeries.
Disqualifiers
Patients whose parents or legal guardians refuse to participate.
Preoperative mechanical ventilation.
Preoperative inotropic drug infusion.
Coagulopathy.
Trial design
Parallel
Treatments tested in this trial
superficial parasternal intercostal Plane block
Procedure/SurgeryA high-frequency linear transducer was used to guide the insertion of a needle 2 cm lateral to the sternum. After identifying key anatomical structures, the needle was advanced in-plane into the pectointercostal fascial plane between the pectoralis major and internal intercostal muscle. Correct placement was confirmed with a saline injection, and then a local anesthetic (0.4 ml/kg of a 1:1 mix of bupivacaine 0.25% and lidocaine 1%) was injected bilaterally at the second and fourth ribs.
Erecto spinea plane block
Procedure/SurgeryUsing ultrasound, a needle is inserted near the T5 vertebra into the plane beneath the erector spinae muscle. After confirming correct positioning with saline, a local anesthetic mixture is injected in the fascial plane.
Treatment groups
Trial outcomes
Primary outcomes
Pain assessment
Pain was assessed by the pediatric observational 10-point scale "Face, Leg, Activity, Cry, Consolability (FLACC) pain score.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.